encephalitis
Information
- Disease name
- encephalitis
- Disease ID
- DOID:9588
- Description
- "A brain disease that is characterized as an acute inflammation of the brain with flu-like symptoms." [url:http\://en.wikipedia.org/wiki/Encephalitis, url:http\://www.mayoclinic.org/diseases-conditions/encephalitis/basics/definition/con-20021917, url:http\://www.nlm.nih.gov/medlineplus/encephalitis.html]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04190303 | Active, not recruiting | BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally | February 17, 2021 | December 31, 2024 | |
| NCT00031486 | Completed | Phase 3 | Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir | September 2000 | February 2011 |
| NCT00069303 | Completed | Natural History of West Nile Virus Infection | September 16, 2003 | February 18, 2011 | |
| NCT00314132 | Completed | Phase 3 | Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. | October 2005 | November 2006 |
| NCT00381433 | Completed | Phase 1 | Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid | September 2006 | June 2009 |
| NCT00981175 | Completed | Phase 2 | A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults | April 2003 | February 2008 |
| NCT01001988 | Completed | Phase 3 | Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers | August 7, 2009 | October 16, 2013 |
| NCT01041573 | Completed | Phase 3 | Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population | March 2010 | July 2011 |
| NCT01047839 | Completed | Phase 3 | Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries | January 2010 | August 2013 |
| NCT01092507 | Completed | Phase 3 | A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers | March 2010 | October 2011 |
| NCT01694524 | Completed | Nervous System Infections Among Patients With Febrile Seizure | June 2013 | March 2014 | |
| NCT02308982 | Completed | Phase 3 | Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis | January 2016 | September 2022 |
| NCT02367664 | Completed | Phase 3 | A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants | October 2014 | June 2016 |
| NCT02526550 | Completed | Phase 4 | Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX | June 2014 | July 2014 |
| NCT02538094 | Completed | N/A | tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis | September 2014 | June 30, 2019 |
| NCT02714959 | Completed | Phase 1/Phase 2 | IL-2 in Refractory Autoimmune Encephalitis | March 2016 | June 12, 2019 |
| NCT02856451 | Completed | Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab | December 9, 2015 | December 31, 2020 | |
| NCT02906631 | Completed | Epidemiology and Prognosis of Encephalitis in Intensive Care | October 27, 2017 | December 1, 2023 | |
| NCT02910037 | Completed | N/A | Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort | June 1, 2016 | July 31, 2017 |
| NCT00001648 | Completed | Structure of the Herpes Simplex Virus Receptor | August 20, 1997 | April 13, 2010 | |
| NCT03144570 | Completed | EURopean Study on Encephalitis in Intensive CAre | June 1, 2017 | December 31, 2020 | |
| NCT03206541 | Completed | Neurologic Manifestations of the Arbovirus Infection in Colombia | January 1, 2016 | December 31, 2019 | |
| NCT03710278 | Completed | The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat) | December 21, 2017 | January 23, 2019 | |
| NCT03826056 | Completed | N/A | Neurology Inpatient Clinical Education Trial | February 1, 2019 | December 7, 2021 |
| NCT04080921 | Completed | Phase 1/Phase 2 | Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis | June 16, 2014 | August 30, 2019 |
| NCT04323150 | Completed | N/A | The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. | February 1, 2018 | December 31, 2020 |
| NCT04325685 | Completed | N/A | The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia | January 1, 2020 | November 7, 2023 |
| NCT05370573 | Completed | Brazil ICU Encephalitis Surveillance | June 1, 2019 | January 1, 2022 | |
| NCT06368648 | Not yet recruiting | CoMind Early Feasibility Study | June 2024 | April 2025 | |
| NCT04722328 | Not yet recruiting | Establishment of Prevention and Control System of Central Nervous System Infection | March 1, 2021 | December 31, 2025 | |
| NCT06283901 | Recruiting | Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of Consciousness | January 2, 2023 | September 1, 2025 | |
| NCT05413733 | Recruiting | N/A | Neuropsychological Rehabilitation Over the Internet | August 1, 2022 | December 31, 2024 |
| NCT06067750 | Recruiting | Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation | June 27, 2023 | June 30, 2024 | |
| NCT04372615 | Recruiting | Phase 2 | The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis | March 30, 2022 | August 31, 2026 |
| NCT02979951 | Recruiting | Fosfomycin i.v. for Treatment of Severely Infected Patients | December 2016 | December 2030 | |
| NCT03418441 | Recruiting | Central Nervous System Infections in Denmark | January 1, 2015 | January 1, 2030 | |
| NCT05393492 | Recruiting | N/A | Regulating Emotions and Behaviors After Brain Injury | May 19, 2022 | December 2025 |
| NCT04361344 | Terminated | N/A | Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection | May 19, 2020 | October 25, 2020 |
| NCT00927953 | Terminated | Phase 2 | Treatment of West Nile Virus With MGAWN1 | May 2009 | May 2011 |
| NCT04001270 | Unknown status | Core Cerebrospinal Fluid Biomarker Profile in Anti-Leucine Rich Glioma Inactivated 1 (Anti-LGI1) Encephalitis | July 15, 2019 | November 15, 2019 | |
| NCT03776994 | Unknown status | Phase 1 | Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine | July 17, 2018 | April 2021 |
| NCT04089436 | Unknown status | SouthEast Asia Encephalitis Project | July 15, 2014 | December 31, 2019 | |
| NCT04460599 | Unknown status | Neurological Features During COVID19 | March 8, 2020 | September 30, 2020 | |
| NCT04946682 | Unknown status | N/A | Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment | April 14, 2021 | April 30, 2023 |
- Disase is a (Disease Ontology)
- DOID:936
- Cross Reference ID (Disease Ontology)
- MESH:D004660
- Cross Reference ID (Disease Ontology)
- NCI:C26760
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:267682000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0014038
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002383
- MedGen concept unique identifier (MedGen Concept name)
- C0014038
- MedGen unique identifier (MedGen Concept name)
- 4027
- MeSH unique ID (MeSH (Medical Subject Headings))
- D004660